Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGMT-NET: Chemotherapy in Neuroendocrine Tumors
NCT03217097Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2018
- Primary completion
- Jan 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in Neuroendocrine Neoplasm (NEN), sponsored by Hospices Civils de Lyon. Started Oct 2018; status: completed.
02
Drugs
oxaliplatin
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT03217097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217097.